Meyer Handelman CO Eli Lilly & CO Transaction History

Meyer Handelman CO

$2.92 Billion
Q3 2024

A detailed history of Meyer Handelman CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Meyer Handelman CO holds 29,016 shares of LLY stock, worth $22.6 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

29,016

Previous 29,764 2.51%

Holding current value

$22.6 Million

Previous $26.9 Million 4.61%

% of portfolio

0.88%

Previous 0.95%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$772.14 - $960.02 $577,560 - $718,094	-748 Reduced 2.51%	29,016 $25.7 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $275,450 - $345,435	-380 Reduced 1.26%	29,764 $26.9 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $544,231 - $728,105	-919 Reduced 2.96%	30,144 $23.5 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $73,899 - $101,880	-170 Reduced 0.54%	31,063 $16.7 Million
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $105,222 - $140,694	-300 Reduced 0.95%	31,233 $14.6 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $310,630 - $364,820	-1,000 Reduced 3.07%	31,533 $10.8 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $409,976 - $477,704	-1,275 Reduced 3.77%	32,533 $11.9 Million
Q3 2022 Oct 04, 2022	SELL	$296.48 - $337.87 $118,592 - $135,148	-400 Reduced 1.17%	33,808 $10.9 Million
Q2 2022 Jul 15, 2022	SELL	$278.73 - $327.27 $83,619 - $98,181	-300 Reduced 0.87%	34,208 $11.1 Million
Q1 2022 Apr 06, 2022	SELL	$234.69 - $291.66 $445,911 - $554,154	-1,900 Reduced 5.22%	34,508 $9.88 Million
Q4 2021 Jan 25, 2022	SELL	$224.85 - $279.04 $44,970 - $55,808	-200 Reduced 0.55%	36,408 $10.1 Million
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 0.54%	36,608 $6.84 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $84,799 - $112,209	-650 Reduced 1.74%	36,808 $6.22 Million
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $58,488 - $67,652	-400 Reduced 1.06%	37,458 $5.55 Million
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $27,283 - $32,836	-200 Reduced 0.53%	37,858 $6.22 Million
Q1 2018 Apr 23, 2018	SELL	$74.21 - $87.6 $22,262 - $26,280	-300 Reduced 0.78%	38,058 $2.95 Million
Q4 2017 Feb 07, 2018	SELL	$81.94 - $87.89 $57,358 - $61,523	-700 Reduced 1.79%	38,358 $3.24 Million
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $3.01 Million - $3.34 Million	39,058	39,058 $3.34 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Eli Lilly & CO Transaction History